RITOR: Does Post-operative Rinsing With a Monoject Syringe Result in as Much Post-operative Pain After Surgical Removal of Lower Impact Third Molars as no Post-operative Rinsing: a Randomized Controlled Equivalence Trial

Sponsor
Isala (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05860686
Collaborator
(none)
150
2
11

Study Details

Study Description

Brief Summary

Many authors have advocated different methods of treating alveolar osteitis. Despite many years of research, however, little progress has been made and so a study with large enough sample and standard outcome measures is warranted.

Goal of this study is assess the effect of postoperative use of a monoject syringe on postoperative complaints after surgical removal of a lower third molar.

Condition or Disease Intervention/Treatment Phase
  • Other: Monoject syringe
N/A

Detailed Description

One of the most common postoperative complications after the removal of a third molar is a condition known as dry socket. This term has been in use since 1896. Since then several other terms have been used, including alveolar osteitis, postoperative alveolitis, alveolitis, sicca dolorosa and fibriniolytic alveolitis. Bim labelled the complication fibrinolytic alveolitis which is the most accurate of the terms, but also the least used. The condition has generally been characterised by delayed healing associated with degradadtion of clot, and is usually accompanied by persistent, radiating, pain postoperativively in and around the extraction site that is not easily relieved by analgesics. Because of the pain, swelling and trismus, patients also tend to have a greater need for painkillers. If it is possible to reduce the amount and severity of postoperative pain felt by patients the postoperative period would be more endurable, the quality of life will be less affected, and in addition to this it is possible that the amount of analgesics taken by patients after surgery could be lowered7. It can be a burden for both patients an surgeons and my result in a loss of productivity because at least 45% of patients require multiple visits to the surgeon.

Objective of the study:

Many authors have advocated different methods of treating alveolar osteitis. Despite many years of research, however, little progress has been made and so a study with large enough sample and standard outcome measures is warranted.

Goal of this study is assess the effect of postoperative use of a monoject syringe on postoperative complaints after surgical removal of a lower third molar

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Double blind randomized clinical trialDouble blind randomized clinical trial
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Does Post-operative Rinsing With a Monoject Syringe Result in as Much Post-operative Pain After Surgical Removal of Lower Impact Third Molars as no Post-operative Rinsing: a Randomized Controlled Equivalence Trial
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: No rinsing

Other: Monoject syringe
monoject syringe is used to clean the wound

Experimental: Monoject rinsing

Other: Monoject syringe
monoject syringe is used to clean the wound

Outcome Measures

Primary Outcome Measures

  1. NRS pain [7 days after treatment]

    pain score

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • In order to be eligible to participate in this study, a subject must meet all of the following criteria: patients over 18 years of age (non-smoking) referred for removal of a wisdom tooth in the mandible. Patient has ASA I.
Exclusion Criteria:
  • Patient is younger than 18 years

Patient has an ASA of II,III en IV

Patient has only one maxillary third molar that needs to be extracted/removed

Patient has an active pericoronitis

In case of planned coronectomy

Patient has trismus

Patient has chronic pain

Patient is pregnant

Patient has a known allergy for ibuprofen of other NSAID's

Patient has a known allergy for articaine of epinefrine

Intra-operative compilations for example excessive bleeding

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Isala

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeroen van der Sleen, Oral an Maxillo facial surgeon, Isala
ClinicalTrials.gov Identifier:
NCT05860686
Other Study ID Numbers:
  • NL81366.075.22
First Posted:
May 16, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2023